Inozyme Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BERYL CAPITAL MANAGEMENT LLC | 08/14/2025 | 6.32 M | $25.29 M | 100.00% | 9.83% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2025 | 4.49 M | $17.98 M | 0.00% | 6.99% |
| GLAZER CAPITAL, LLC | 08/14/2025 | 4.33 M | $17.32 M | 100.00% | 6.74% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2025 | 4.28 M | $17.12 M | 0.00% | 6.66% |
| ODDO BHF ASSET MANAGEMENT SAS | 08/14/2025 | 3.20 M | $12.80 M | 100.00% | 4.98% |
| TRIUM CAPITAL LLP | 08/11/2025 | 3.17 M | $12.69 M | 100.00% | 4.94% |
| BLACKROCK, INC. | 08/12/2025 | 2.66 M | $10.65 M | -28.88% | 4.14% |
| VANGUARD GROUP INC | 08/11/2025 | 2.50 M | $9.99 M | -9.42% | 3.89% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2025 | 2.44 M | $9.75 M | 0.00% | 3.79% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 08/05/2025 | 2.19 M | $8.75 M | 100.00% | 3.40% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2025 | 1.75 M | $7.00 M | -54.77% | 2.72% |
| GABELLI FUNDS LLC | 08/13/2025 | 1.46 M | $5.83 M | 100.00% | 2.27% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 08/12/2025 | 1.26 M | $5.03 M | 100.00% | 1.96% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 1.22 M | $4.89 M | -0.78% | 1.90% |
| OMERS ADMINISTRATION CORP | 08/13/2025 | 1.12 M | $4.47 M | 100.00% | 1.74% |
| MAN GROUP PLC | 08/14/2025 | 670.16 K | $2.68 M | 100.00% | 1.04% |
| KNOTT DAVID M JR | 08/11/2025 | 666.20 K | $2.66 M | 0.00% | 1.04% |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 08/13/2025 | 617.00 K | $2.47 M | 100.00% | 0.96% |
| WOODLINE PARTNERS LP | 08/14/2025 | 535.19 K | $2.14 M | -46.68% | 0.83% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 481.80 K | $1.93 M | -61.29% | 0.75% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 470.50 K | $1.88 M | -16.65% | 0.73% |
| SANOFI | 07/29/2025 | 443.26 K | $1.77 M | 0.00% | 0.69% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 08/13/2025 | 377.23 K | $1.51 M | 100.00% | 0.59% |
| OXFORD ASSET MANAGEMENT LLP | 08/14/2025 | 361.56 K | $1.45 M | 100.00% | 0.56% |
| STATE STREET CORP | 08/14/2025 | 331.77 K | $1.33 M | -66.73% | 0.52% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2025 | 260.71 K | $1.04 M | 100.00% | 0.41% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 224.98 K | $899.92 K | 110.51% | 0.35% |
| GROUPE LA FRANCAISE | 08/13/2025 | 223.80 K | $895.20 K | 100.00% | 0.35% |
| WATER ISLAND CAPITAL LLC | 08/14/2025 | 201.78 K | $807.10 K | 100.00% | 0.31% |
| GOLDMAN SACHS GROUP INC | 08/14/2025 | 155.01 K | $620.03 K | -33.63% | 0.24% |
| CREDIT INDUSTRIEL ET COMMERCIAL | 08/07/2025 | 149.20 K | $596.80 K | 100.00% | 0.23% |
| NORTHERN TRUST CORP | 08/13/2025 | 139.07 K | $556.30 K | -67.52% | 0.22% |
| CITADEL ADVISORS LLC | 08/14/2025 | 128.70 K | $514.80 K | 832.61% | 0.20% |
| MORGAN STANLEY | 08/15/2025 | 124.74 K | $498.94 K | -8.60% | 0.19% |
| DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 120.15 K | $480.58 K | -52.34% | 0.19% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 08/14/2025 | 90.70 K | $362.80 K | 100.00% | 0.14% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2025 | 84.65 K | $338.59 K | 100.00% | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 82.61 K | $330.44 K | -6.22% | 0.13% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2025 | 80.61 K | $322.46 K | 1.94% | 0.13% |
| SUMMITTX CAPITAL, L.P. | 08/14/2025 | 79.57 K | $318.30 K | 100.00% | 0.12% |
| JAIN GLOBAL LLC | 08/14/2025 | 70.64 K | $282.57 K | 100.00% | 0.11% |
| XTX TOPCO LTD | 08/12/2025 | 70.17 K | $280.68 K | -36.60% | 0.11% |
| GAMCO INVESTORS, INC. ET AL | 08/13/2025 | 60.00 K | $240.00 K | 100.00% | 0.09% |
| WOLVERINE ASSET MANAGEMENT LLC | 08/04/2025 | 58.44 K | $233.78 K | 100.00% | 0.09% |
| JPMORGAN CHASE & CO | 08/12/2025 | 57.43 K | $229.74 K | 84.25% | 0.09% |
| JANE STREET GROUP, LLC | 08/14/2025 | 55.77 K | $223.06 K | 100.00% | 0.09% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2025 | 55.52 K | $222.00 K | 100.00% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 52.45 K | $209.82 K | -27.50% | 0.08% |
| MARSHALL WACE, LLP | 08/13/2025 | 50.90 K | $203.60 K | 100.00% | 0.08% |
| HARVEST MANAGEMENT LLC | 08/14/2025 | 50.00 K | $200.00 K | 100.00% | 0.08% |
Inozyme Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 93 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:
UBS Group AG: 0
ODDO BHF ASSET MANAGEMENT SAS: 0
INTECH INVESTMENT MANAGEMENT LLC: 0
XTX Topco Ltd: 0
OMERS ADMINISTRATION Corp: 0
Woodline Partners LP: 0
78.66% of Inozyme Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.11 M shares in the last 24 months. This purchase volume represents approximately $20.43 M in transactions.